Yumanity Therapeutics, Inc. YMTX
Set alert
1.89 +1.89 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 20.52M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.38
- Beta
- 0.00
- Short ratio
- 1.24
- Inst. own
- 22.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 14, 2022
- 50-d avg
- 1.77
- 200-d avg
- 1.59
- 1y target
- 35.00
Ownership
Held by insiders 19.62%
Held by institutions 22.57%
Float held by institutions 28.08%
Institutions 18
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 15.00% | 1,628,470 | 3.08M | Sep 29, 2022 |
| Vanguard Group, Inc. (The) | 2.42% | 262,343 | 495.83K | Sep 29, 2022 |
| Artal Group S.A. | 2.00% | 217,391 | 410.87K | Sep 29, 2022 |
| Renaissance Technologies, LLC | 0.63% | 68,722 | 129.88K | Sep 29, 2022 |
| Geode Capital Management, LLC | 0.51% | 55,533 | 104.96K | Sep 29, 2022 |
| Citadel Advisors Llc | 0.46% | 49,543 | 93.64K | Sep 29, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 4.69% | 509,001 | 962.01K | Oct 30, 2022 |
| Fidelity Select Portfolios - Biotechnology | 2.40% | 260,182 | 491.74K | Oct 30, 2022 |
| Vanguard Total Stock Market Index Fund | 2.13% | 230,835 | 436.28K | Sep 29, 2022 |
| Fidelity Growth Company K6 Fund | 1.23% | 133,373 | 252.07K | Oct 30, 2022 |
| Fidelity Series Growth Company Fund | 0.76% | 82,392 | 155.72K | Oct 30, 2022 |
| Vanguard Extended Market Index Fund | 0.27% | 29,192 | 55.17K | Sep 29, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COLES N. ANTHONY | Officer and Director | Stock Award(Grant) | Jan 31, 2021 | 743,677 |
| EPSTEIN MARIE N. | Officer | Sale | Dec 1, 2022 | 8,883 |
| HEYMAN RICHARD A | Director | Stock Award(Grant) | Jan 31, 2021 | 8,117 |
| KELLY JEFFERY W. | Director | Stock Award(Grant) | Jan 31, 2021 | 13,237 |
| MOHSEN PAULASH | Officer | Sale | Feb 2, 2022 | 59,135 |
| PETERS RICHARD | Chief Executive Officer | Sale | Dec 1, 2022 | 90,028 |